clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Carcinoma, Lewis Lung D018827 22 associated lipids
Fibrosis D005355 23 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Gastritis D005756 27 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Angina Pectoris D000787 27 associated lipids
Endometriosis D004715 29 associated lipids
Proteinuria D011507 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Diarrhea D003967 32 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Fever D005334 35 associated lipids
Heart Failure D006333 36 associated lipids
Lung Diseases D008171 37 associated lipids
Arthritis D001168 41 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Psoriasis D011565 47 associated lipids
Parkinson Disease D010300 53 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Pain D010146 64 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Colitis D003092 69 associated lipids
Hyperlipidemias D006949 73 associated lipids
Stomach Ulcer D013276 75 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Insulin Resistance D007333 99 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Glatstein M et al. Lung abscess due to non-tuberculous, non-Mycobacterium fortuitum in a neonate. 2012 Pediatr. Pulmonol. pmid:22451300
Matsushima M and Takagi A "Is it effective?" to "How to use it?": the era has changed in probiotics and functional food products against Helicobacter pylori infection. 2012 J. Gastroenterol. Hepatol. pmid:22515805
Fujita Y et al. Pulmonary Actinomyces graevenitzii infection presenting as organizing pneumonia diagnosed by PCR analysis. 2012 J. Med. Microbiol. pmid:22516132
Albaugh DR et al. Time-dependent inhibition and estimation of CYP3A clinical pharmacokinetic drug-drug interactions using plated human cell systems. 2012 Drug Metab. Dispos. pmid:22490230
Malfertheiner P et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. 2012 Gut pmid:22491499
Huang YK et al. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. 2012 J Dig Dis pmid:22435509
Brož P et al. Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. 2012 Allergy pmid:22435670
Hojsak I et al. Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience. 2012 Eur. J. Pediatr. pmid:22430353
Padovan J et al. Investigating the barriers to bioavailability of macrolide antibiotics in the rat. 2012 Eur J Drug Metab Pharmacokinet pmid:22113743
Walkey AJ and Wiener RS Macrolide antibiotics and survival in patients with acute lung injury. 2012 Chest pmid:22116799
Reva I et al. Virulence genotypes and drug resistance of Helicobacter pylori from Vladivostok, Russia: another feature in the Far East. 2012 Microbiol. Immunol. pmid:22211953
Park SJ et al. Fulminant and Fatal Multiple Organ Failure in a 12-Year-Old Boy With Mycoplasma pneumoniae Infection. 2012 Allergy Asthma Immunol Res pmid:22211173
Falkinham JO et al. Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. 2012 Tuberculosis (Edinb) pmid:22209468
Ohtani M et al. Amino acid and vitamin supplementation improved health conditions in elderly participants. 2012 J Clin Biochem Nutr pmid:22448099
Park HS et al. Placental transfer of clarithromycin in human pregnancies with preterm premature rupture of membranes. 2012 J Perinat Med pmid:23095192
Yamazaki Y et al. Antimicrobial and anti-inflammatory effects of clarithromycin on Mycobacterium avium complex replication in cultured human bronchial epithelial cells. 2012 J. Infect. Chemother. pmid:22370922
Kim HS et al. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy. 2012 Radiology pmid:22371609
Hutson JR et al. Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study. 2012 Drugs Aging pmid:22372724
Hegazy SK et al. Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers. 2012 Eur. J. Clin. Pharmacol. pmid:22392555
Valizadeh H et al. Antibacterial activity of clarithromycin loaded PLGA nanoparticles. 2012 Pharmazie pmid:22393833
Togami K et al. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections. 2012 J Aerosol Med Pulm Drug Deliv pmid:22360316
Gisbert JP and Calvet X Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. 2012 Aliment. Pharmacol. Ther. pmid:22129228
Shiotani A et al. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. 2012 J. Gastroenterol. pmid:22382634
Nujić K et al. Valosin containing protein (VCP) interacts with macrolide antibiotics without mediating their anti-inflammatory activities. 2012 Eur. J. Pharmacol. pmid:22209877
Hiramatsu M et al. Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. 2012 Ann. Thorac. Surg. pmid:22119119
Kanazu T et al. Investigation of drug-drug interaction via mechanism-based inhibition of cytochrome P450 3A by macrolides in dexamethasone-treated female rats. 2012 Biopharm Drug Dispos pmid:22447511
Togami K et al. Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells. 2012 Pharmazie pmid:22764569
Konorev MR [Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy]. 2012 Ter. Arkh. pmid:23479993
Inamo Y et al. A 7-year-old girl with subcutaneous emphysema, pneumomediastinum, pneumothorax, and pneumoretroperitoneum caused by Mycoplasma pneumoniae pneumonia. 2012 J. Infect. Chemother. pmid:21901497
Diacon AH et al. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. 2012 Antimicrob. Agents Chemother. pmid:22391540
Madi D et al. Successful treatment of cerebral toxoplasmosis with clindamycin: a case report. 2012 Oman Med J pmid:23074553
Qian J et al. Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China. 2012 Helicobacter pmid:23067317
Sezikli M et al. Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori. 2012 J Clin Pharm Ther pmid:21740452
Liang J et al. Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trial. 2012 Helicobacter pmid:23066868
Erol E et al. Antibiotic susceptibility patterns of Crossiella equi and Amycolatopsis species causing nocardioform placentitis in horses. 2012 J. Vet. Diagn. Invest. pmid:23051830
Dalkmann P et al. Accumulation of pharmaceuticals, Enterococcus, and resistance genes in soils irrigated with wastewater for zero to 100 years in central Mexico. 2012 PLoS ONE pmid:23049795
Kurugol Z et al. Severe Hemolytic Anemia Associated with Mild Pneumonia Caused by Mycoplasma pneumonia. 2012 Case Rep Med pmid:23049568
Deng ZH et al. Influence of Helicobacter pylori infection on ghrelin levels in children. 2012 World J. Gastroenterol. pmid:23049220
Malfertheiner P et al. Helicobacter pylori: clinical management. 2012 Curr. Opin. Gastroenterol. pmid:23010682
Tepes B et al. Treatment of Helicobacter pylori infection 2012. 2012 Helicobacter pmid:22958154
Jang YJ et al. Maxillary sinus hypoplasia with a patent ostiomeatal complex: A therapeutic dilemma. 2012 Auris Nasus Larynx pmid:21571467
Hansomburana P et al. Prevalence of single nucleotide mutation in clarithromycin resistant gene of Helicobacter pylori: a 32-months prospective study by using hybridization real time polymerase chain reaction. 2012 J Med Assoc Thai pmid:22619884
Rimbara E et al. Molecular epidemiologic analysis and antimicrobial resistance of Helicobacter cinaedi isolated from seven hospitals in Japan. 2012 J. Clin. Microbiol. pmid:22593597
Hu FL et al. [Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study]. 2012 Zhonghua Yi Xue Za Zhi pmid:22781295
Kant S et al. Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient. 2012 BMJ Case Rep pmid:22605844
Kotsaki A and Giamarellos-Bourboulis EJ Emerging drugs for the treatment of sepsis. 2012 Expert Opin Emerg Drugs pmid:22780561
Kurinčič M et al. Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics. 2012 Int. J. Antimicrob. Agents pmid:22999765
Korkmaz S et al. Unusual manifestations of acute Q fever: autoimmune hemolytic anemia and tubulointerstitial nephritis. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:22607576
Fiorini G et al. Newer agents for Helicobacter pylori eradication. 2012 Clin Exp Gastroenterol pmid:22767998
Whittemore KR and Cohen M Imaging and review of a large pre-auricular pilomatrixoma in a child. 2012 World J Radiol pmid:22761984
Oh HS et al. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study. 2012 J. Gastroenterol. Hepatol. pmid:21916989
Suzuki H et al. Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan. 2012 Keio J Med pmid:23324305
Kudo T et al. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study. 2012 Helicobacter pmid:22759327
Wong BC et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. 2012 Gut pmid:21917649
Roccarina D et al. Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication. 2012 Dig Liver Dis pmid:22743557
Tursi A et al. Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection. 2012 J Gastrointestin Liver Dis pmid:22720300
Giguère S et al. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi. 2012 Vet. Microbiol. pmid:22704561
O'Connor MB et al. Rituximab-induced pulmonary disease. 2012 Rheumatol. Int. pmid:21892654
Nakagawa T et al. [Multicenter study on clinical features and genetic characteristics of Mycobacterium avium strains from patients in Japan with lung disease caused by M. avium]. 2012 Kekkaku pmid:23367826
Gochi M et al. [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report]. 2012 Kekkaku pmid:23367833
Birteksöz-Tan AS and Zeybek Z Postantibiotic effect of various antibiotics on Legionella pneumophila strains isolated from water systems. 2012 Folia Microbiol. (Praha) pmid:22627604
Burt HJ et al. Progress curve mechanistic modeling approach for assessing time-dependent inhibition of CYP3A4. 2012 Drug Metab. Dispos. pmid:22621802
Bermudez LE et al. Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice. 2012 Antimicrob. Agents Chemother. pmid:22615290
Khan A et al. Antibiotic resistance and cagA gene correlation: a looming crisis of Helicobacter pylori. 2012 World J. Gastroenterol. pmid:22611319
Chhabra N et al. Pharmacotherapy for multidrug resistant tuberculosis. 2012 J Pharmacol Pharmacother pmid:22629081
Prasad R Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies. 2012 Lung India pmid:22628931
Ankomah P and Levin BR Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum. 2012 PLoS Pathog. pmid:22253599
Melter O et al. Bartonella quintana transmission from mite to family with high socioeconomic status. 2012 Emerging Infect. Dis. pmid:22257438
Kjoller E et al. Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease. 2012 J Clin Epidemiol pmid:22257841
Suzuki T Meibomitis-related keratoconjunctivitis: implications and clinical significance of meibomian gland inflammation. 2012 Cornea pmid:23038034
Kamada T et al. [Case of acute pharyngitis caused by Corynebacterium ulcerans in Ibaraki Prefecture]. 2012 Nippon Jibiinkoka Gakkai Kaiho pmid:22991854
Ichiki H et al. [A study of adverse drug reactions in the treatment of pulmonary Mycobacterium avium complex disease]. 2012 Kekkaku pmid:22993889
Schluger NW Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter? 2012 Am. J. Respir. Crit. Care Med. pmid:23071188
Li K and Haber RM Stevens-Johnson syndrome without skin lesions (Fuchs syndrome): a literature review of adult cases with Mycoplasma cause. 2012 Arch Dermatol pmid:22911206
Alfakry H et al. The association of serum neutrophil markers and acute coronary syndrome. 2012 Scand. J. Immunol. pmid:22537345
Shaifali I et al. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. 2012 N Am J Med Sci pmid:22536558
Gisbert JP Rescue Therapy for Helicobacter pylori Infection 2012. 2012 Gastroenterol Res Pract pmid:22536225
Lee RP et al. Mycobacterium chelonae infection after total knee arthroplasty: a case report. 2012 J Orthop Surg (Hong Kong) pmid:22535831
Shaaban HS et al. Mycobacterium chelonae infection of the parotid gland. 2012 J Glob Infect Dis pmid:22529633
Karlgren M et al. Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. 2012 J. Med. Chem. pmid:22541068
Senhorinho GN et al. Occurrence and antimicrobial susceptibility of Porphyromonas spp. and Fusobacterium spp. in dogs with and without periodontitis. 2012 Anaerobe pmid:22609780
Adrjanowicz K et al. Molecular dynamics in supercooled liquid and glassy states of antibiotics: azithromycin, clarithromycin and roxithromycin studied by dielectric spectroscopy. Advantages given by the amorphous state. 2012 Mol. Pharm. pmid:22540343
Lulitanond A et al. Prevalence of β-lactamase-negative ampicillin-resistant haemophilus influenzae isolated from patients of a teaching hospital in Thailand. 2012 Jpn. J. Infect. Dis. pmid:22446118
Liang Y et al. Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children. 2012 J. Med. Microbiol. pmid:22442290
Gomez-Abreo D et al. [Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense]. 2012 Rev Mal Respir pmid:22440310
Ishii H et al. Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection. 2012 J. Infect. pmid:22178990
Aoyama N et al. Clarithromycin suppresses the periodontal bacteria-accelerated abdominal aortic aneurysms in mice. 2012 J. Periodont. Res. pmid:22181324
Slany M et al. Mycobacterium marinum infections in humans and tracing of its possible environmental sources. 2012 Can. J. Microbiol. pmid:22182182
Guillot S et al. Macrolide-resistant Bordetella pertussis infection in newborn girl, France. 2012 Emerging Infect. Dis. pmid:22608348
Carella AM et al. Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia. 2012 Leuk. Lymphoma pmid:22233113
Lee JH et al. A nanohybrid system for taste masking of sildenafil. 2012 Int J Nanomedicine pmid:22619517
van Ingen J et al. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. 2012 Am. J. Respir. Crit. Care Med. pmid:22744719
Lachter J et al. Yellow brain culinary-medicinal mushroom, Tremella mesenterica Ritz.:Fr. (higher Basidiomycetes), is subjectively but not objectively effective for eradication of Helicobacter pylori: a prospective controlled trial. 2012 Int J Med Mushrooms pmid:22339708
Terada M et al. Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium. 2012 J. Infect. Chemother. pmid:22020630
Song JY et al. Case series of mycobacterium abscessus infections associated with a trigger point injection and epidural block at a rural clinic. 2012 Epidemiol Health pmid:22323979
Hirata Y et al. Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan. 2012 Int. J. Antimicrob. Agents pmid:22321702
Pereyre S et al. Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. 2012 Emerging Infect. Dis. pmid:22305177
Butler CC et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. 2012 BMJ pmid:22302780
Anand TD et al. Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:22296671
Correia M et al. Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. 2012 PLoS ONE pmid:22529974